The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combination of Tim-3 blockade TQB2618 with penpulimab and chemotherapy in the first-line treatment of recurrent/metastatic nasopharyngeal carcinoma (R/M NPC): A multicenter, single-arm, two-cohort, phase 2 study.
 
Cheng Xu
No Relationships to Disclose
 
Qingqing Cai
No Relationships to Disclose
 
Jun Ma
Research Funding - Bristol Myers Squibb Foundation; Varian Medical Systems
 
Kunyu Yang
No Relationships to Disclose
 
Siyang Wang
No Relationships to Disclose
 
Liangfang Shen
No Relationships to Disclose
 
Song Qu
No Relationships to Disclose
 
Jing Huang
No Relationships to Disclose
 
Xinqiong Huang
No Relationships to Disclose
 
Ling-Long Tang
No Relationships to Disclose
 
Yingpeng Peng
No Relationships to Disclose
 
Yi Xia
No Relationships to Disclose
 
Liangliang Shi
No Relationships to Disclose
 
Fan Zhang
No Relationships to Disclose
 
Jianming Gao
No Relationships to Disclose
 
Yan-Ping Mao
No Relationships to Disclose
 
Rui Guo
No Relationships to Disclose
 
Xiaohua Hong
No Relationships to Disclose
 
Zhanjie Zhang
No Relationships to Disclose
 
Ying Sun
No Relationships to Disclose